Jump to navigation
The Limesand Lab at the University of Arizona is devoted to improving quality of life for head-and-neck cancer survivors, who often suffer from irreversible dry mouth.
To Develop New Immunotherapies, Collaboration Is Key
Immunotherapy can backfire when a supercharged immune system attacks healthy cells, but researchers are hopeful for the future.
Rachna Shroff, MD, led a landmark study on the use of targeted drugs called PARP inhibitors in pancreatic cancer patients with BRCA mutations.
The company targets accelerated diagnosis and treatment of cancer by providing optimal tissue samples for effective personalized medicine.
Designer antibodies, like checkpoint inhibitors, have revolutionized cancer treatment.
Joint statement empowers parents, young adults and physicians to increase vaccination rates and screenings to eliminate HPV-related cancers, starting with cervical cancer.
The four-year National Cancer Institute grant will enable Terry A. Badger, PhD, RN, PMHCNS-BC, FAAN, to study whether psychosocial interventions will help ethnically diverse survivors improve their symptoms.
Melissa Herbst-Kralovetz of the University of Arizona Cancer Center and UA College of Medicine – Phoenix has found that an imbalance of vaginal bacteria is associated with cervical cancer risk.